The cholinesterase inhibitor DFP facilitates the expression of paradoxical sleep (PS) propensity in rats subjected to short-term PS deprivation

Brain Research

Volumn 965, Issue 1-2, 2003, Pages 180-186

  Deurveilher, Samuel ^a,b   Hennevin, Elizabeth ^a  

^a CNRS   (France)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cholinergic transmission; Postdeprivation REM sleep rebound; REM sleep attempts during deprivation; REM sleep propensity

Indexed keywords

CHOLINESTERASE INHIBITOR; DYFLOS;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REM SLEEP; REM SLEEP DEPRIVATION; SLEEP PARAMETERS; SLEEP TIME; SLEEP WAKING CYCLE; WAKEFULNESS;

EID: 0037424309     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)04171-9     Document Type: Article

References (41)

1. Baghdoyan H.A. Cholinergic mechanisms regulating REM sleep. Schwartz W.J. Sleep Science: Integrating Basic Research and Clinical Practice. Vol. 15:1997;88-116 Karger, Basle.
2. Benington J.H., Heller H.C. Implications of sleep deprivation experiments for our understanding of sleep homeostasis. Sleep. 22:1999;1033-1037.
3. Benington J.H., Woudenberg M.C., Heller H.C. REM-sleep propensity accumulates during 2-h REM-sleep deprivation in the rest period in rats. Neurosci. Lett. 180:1994;76-80.
4. Borbély A.A., Tobler I., Hanagasioglu M. Effect of sleep deprivation on sleep and EEG power spectra in the rat. Behav. Brain Res. 14:1984;171-182.
5. Bushnell P.J., Padilla S.S., Ward T., Pope C.N., Olszyk V.B. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate. J. Pharmacol. Exp. Ther. 256:1991;741-750.
6. Chippendale T.J., Zawolkow G.A., Russell R.W., Overstreet D.H. Tolerance to low acetylcholinesterase levels: modification of behavior without acute behavioral change. Psychopharmacologia. 26:1972;127-139.
7. Datta S. Neuronal activity in the peribrachial area: Relationship to behavioral state control. Neurosci. Biobehav. Rev. 19:1995;67-84.
8. Datta S., Spoley E.E., Patterson E.H. Microinjection of glutamate into the pedunculopontine tegmentum induces REM sleep and wakefulness in the rat. Am. J. Physiol. 280:2001;R752-R759.
9. Détári L., Rasmusson D.D., Semba K. The role of basal forebrain neurons in tonic and phasic activation of the cerebral cortex. Prog. Neurobiol. 58:1999;249-277.
10. Deurveilher S., Delamanche I.S., Hars B., Breton P., Hennevin E. Chronic, low-level exposure to the cholinesterase inhibitor DFP. I. Time course of neurochemical changes in the rat pontomesencephalic tegmentum. Pharmacol. Biochem. Behav. 64:1999;95-103.
11. Deurveilher S., Hars B., Hennevin E. Pontine microinjection of carbachol does not reliably enhance paradoxical sleep in rats. Sleep. 20:1997;593-607.
12. Deurveilher S., Hars B., Hennevin E. Chronic, low-level exposure to the cholinesterase inhibitor DFP. II. Time course of behavioral state changes in rats. Pharmacol. Biochem. Behav. 64:1999;105-114.
13. Deurveilher S., Hennevin E. Lesions of the pedunculopontine tegmental nucleus reduce paradoxical sleep (PS) propensity: Evidence from a short-term PS deprivation study in rats. Eur. J. Neurosci. 13:2001;1963-1976.
14. Dringenberg H.C., Vanderwolf C.H. Involvement of direct and indirect pathways in electrocorticographic activation. Neurosci. Biobehav. Rev. 22:1998;243-257.
15. Endo T., Roth C., Landolt H.P., Werth E., Aeschbach D., Achermann P., Borbély A.A. Selective REM sleep deprivation in humans: Effects on sleep and sleep EEG. Am. J. Physiol. 274:1998;R1186-R1194.
16. Franken P. Long-term vs. short-term processes regulating REM sleep. J. Sleep Res. 11:2002;17-28.
17. Gnadt J.W., Pegram G.V., Baxter J.F. The acetylcholinesterase inhibitor di-isopropyl-fluorophosphate increases REM sleep in rats. Physiol. Behav. 35:1985;911-916.
18. Jones B. The organization of central cholinergic systems and their functional importance in sleep waking states. Cuello A.C. Progress in Brain Research. Vol. 98:1993;61-71 Elsevier, Amsterdam.
19. Jouvet M. Basic mechanisms: Paradoxical sleep mechanisms. Sleep. 17:(Suppl. 8):1994;S77-S83.
20. Kubin L. Carbachol models of REM sleep: Recent developments and new directions. Arch. Ital. Biol. 139:2001;147-168.
21. Lydic R., Baghdoyan H.A. The neurobiology of rapid-eye-movement sleep. Saunders N.A., Sullivan C.E. Sleep and Breathing. 1994;47-77 Marcel Dekker, New York.
22. McCarley R.W., Greene R.W., Rainnie D., Portas C.M. Brainstem neuromodulation and REM sleep. Semin. Neurosci. 7:1995;341-354.
23. Morden B., Mitchell G., Dement W. Selective REM sleep deprivation and compensation phenomena in the rat. Brain Res. 5:1967;339-349.
24. Mundy W.R., Ward T.R., Dulchinos V.F., Tilson H.A. Effect of repeated organophosphate administration on carbachol-stimulated phosphoinositide hydrolysis in the rat brain. Pharmacol. Biochem. Behav. 45:1993;309-314.
25. Ocampo-Garcés A., Molina E., Rodríguez A., Vivaldi E.A. Homeostasis of REM sleep after total and selective sleep deprivation in the rat. J. Neurophysiol. 84:2000;2699-2702.
26. Rechtschaffen A., Bergmann B.M. Sleep rebounds and their implications for sleep stage substrates: A response to Benington and Heller. Sleep. 22:1999;1038-1043.
27. Rechtschaffen A., Bergmann B.M., Gilliland M.A., Bauer K. Effects of method, duration, and sleep stage on rebounds from sleep deprivation in the rat. Sleep. 22:1999;11-31.
28. Rouanet H., Bernard J.M., Leroux B. Statistiques en Sciences Humaines: Analyse Inductive des Données. 1990;Dunot, Paris.
29. Russell R.W., Overstreet D.H. Mechanisms underlying sensitivity to organophosphorus anticholinesterase compounds. Prog. Neurobiol. 28:1987;97-129.
30. Salín-Pascual R.J., Grandos-Fuentes D., Galicia-Polo L., Nieves E., Echeverry J. Biperiden administration in normal sleep and after rapid eye movement sleep deprivation in healthy volunteers. Neuropsychopharmacology. 5:1991;97-102.
31. Salín-Pascual R.J., Grandos-Fuentes L., Galicia-Polo L., Nieves E., Roehrs T.A., Roth T. Biperiden administration during REM sleep deprivation diminished the frequency of REM sleep attempts. Sleep. 15:1992;252-256.
32. Salín-Pascual R.J., Jimenez-Anguiano A., Granados-Fuentes D., Drucker-Colín R. Effects of biperiden on sleep at baseline and after 72 h of REM sleep deprivation in the cat. Psychopharmacology. 106:1992;540-542.
33. Salín-Pascual R.J., Moro-Lopez M.L., Gonzalez-Sanchez H., Blanco-Centurión C. Changes in sleep after acute and repeated administration of nicotine in the rat. Psychopharmacology. 145:1999;133-138.
34. Salín-Pascual R.J., Nieto-Caraveo A., Roldán-Roldán G., Huerto-Delgadillo L., Granados-Fuentes D. Effects of physostigmine infusion on healthy volunteers deprived of rapid eye movement sleep. Sleep. 12:1989;246-253.
35. Semba K. The mesopontine cholinergic system: A dual role in REM sleep and wakefulness. Lydic R., Baghdoyan H.A. Handbook of Behavioral State Control: Cellular and Molecular Mechanisms. 1999;161-180 CRC Press, Boca Raton, FL.
36. Shiromani P.J., Fishbein W. Continuous pontine cholinergic microinfusion via mini-pump induces sustained alterations in rapid eye movement (REM) sleep. Pharmacol. Biochem. Behav. 25:1986;1253-1261.
37. Steriade M., Buzsáki G. Parallel activation of thalamic and cortical neurons by brainstem and basal forebrain cholinergic systems. Steriade M., Biesold D. Brain Cholinergic Systems. 1990;3-62 Oxford Science Publications, Oxford.
38. Sutin E.L., Shiromani P.J., Kelsoe J.R., Storch F.I., Gillin J.C. Rapid-eye movement sleep and muscarinic receptor binding in rats are augmented during withdrawal from chronic scopolamine treatment. Life Sci. 39:1986;2419-2427.
39. Timofeeva O.A., Gordon C.J. Changes in EEG power spectra and behavioral states in rats exposed to the acetylcholinesterase inhibitor chlorpyrifos and muscarinic agonist oxotremorine. Brain Res. 893:2001;165-177.
40. Timofeeva O.A., Gordon C.J. EEG spectra, behavioral states and motor activity in rats exposed to acetylcholinesterase inhibitor chlorpyrifos. Pharmacol. Biochem. Behav. 72:2002;669-679.
41. Wurts S.W., Edgar D.M. Circadian and homeostatic control of rapid eye movement (REM) sleep: Promotion of REM tendency by the suprachiasmatic nucleus. J. Neurosci. 20:2000;4300-4310.